Symposium 4: Insuline pumps in artificial páncreas systems
DOI:
https://doi.org/10.47196/diab.v54i3Sup.294Keywords:
diabetes, insulinAbstract
Symposium 4: Biology and technology in the treatment of diabetes
Insuline pumps in artificial páncreas systems
By year 2021, insuline discover will reach a centenary. It was the first medication specifically for diabetes treatment and nowadays it is still the safest and most powerful of hypoglycemics. Despite its effectiveness, insuline's greatest challenge has been the occurrence of hypoglycemia, which has resulted in sub-optimal dosing in the prescriptions of nearly every patient. Most popular devices for insuline administration are syringes, pens and insuline pumps. Closed-loop artificial pancreas systems made for extremely demanding aims seem to be very close to becoming a reality. The development of these systems significantly sped up with the great progress of continuous glucose monitors (CGM) along with computerized algorithms.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
